Gene- and cell-based approaches for neurodegenerative disease.

Adv Exp Med Biol. 2010; 671 : 117-30. Gene- and cell-based approaches for neurodegenerative disease. Urbaniak Hunter K, Yarbrough C, Ciacci J. Department of Radiation Oncology, Univesity of Michigan, Ann Arbor, Michigan, USA. kurbania@med.umich.edu Abstract Neurodegenerative diseases comprise an important group ofchronic diseases that increase in incidence with rising age. In particular, the two most…

Stem cell and gene therapies for neurological disorders and intractable epilepsy.

Neuropharmacology. 2010 May; 58(6) : 855-64. Epub 2010 Feb 8. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Naegele JR, Maisano X, Yang J, Royston S, Ribeiro E. Department of Biology and Program in Neuroscience and Behavior, Hall Atwater Laboratory, 52 Lawn Avenue, Wesleyan University, Middletown, CT 06459, USA.…

Stem cell therapy for Parkinson’s disease.

Stem Cells Dev. 2010 Mar; 19(3) : 311-20. Stem cell therapy for Parkinson’s disease: a road map for a successful future. Vidaltamayo R, Bargas J, Covarrubias L, Hernández A, Galarraga E, Gutiérrez-Ospina G, Drucker-Colin R. Depto de Neurociencias and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México. Abstract Cell transplant therapy for Parkinson’s…

Stem cell-derived dopamine neurons for brain repair in Parkinson’s disease.

Regen Med. 2010 Mar; 5(2) : 267-78. Stem cell-derived dopamine neurons for brain repair in Parkinson’s disease. Fricker-Gates RA, Gates MA. Keele University, Keele, Staffordshire, UK. r.a.fricker-gates@hfac.keele.ac.uk Abstract One of the prospects for a curative treatment for Parkinson’s disease is to replace the lost dopaminergic neurons. Preclinical and clinical trials have demonstrated that dissected fetal…

Stem cell transplantation in Parkinson’s disease.

Transl Res. 2010 Feb; 155(2) : 62-70. Epub 2009 Aug 6. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson’s disease. Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, Totey SM. Advanced Neuroscience Institute, BGS-Global Hospital, Bangalore, India. drnkvr@gmail.com Comment…

Clinical application of patient-specific pluripotent stem cells

J Clin Invest. 2010 Jan 4; 120(1) : 51-9. doi: 10.1172/JCI40553. Progress toward the clinical application of patient-specific pluripotent stem cells. Kiskinis E, Eggan K. The Stowers Medical Institute, Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA. ekiskinis@mcb.harvard.edu Abstract Induced pluripotent stem (iPS)…

Human tooth germ stem cells preserve neuro-protective effects after long-term cryo-preservation.

Curr Neurovasc Res. 2010 Feb 1; 7(1) : 49-58. Human tooth germ stem cells preserve neuro-protective effects after long-term cryo-preservation. Yalvaç ME, Ramazanoglu M, Tekguc M, Bayrak OF, Shafigullina AK, Salafutdinov II, Blatt NL, Kiyasov AP, Sahin F, Palotás A, Rizvanov AA. Department of Genetics and BioEngineering, College of Engineering and Architecture, Yeditepe University, Campus,…